Market research
603168.SHG Zhejiang Shapuaisi Pharmaceutical Co.,Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.12
Community
Investor discussion
1 comment
Sign in to join the 603168.SHG discussion.
5 years, 5 months ago
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 12.6% above its 200 day moving average.
From a valuation standpoint, the stock is 27.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.0.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd's total revenue sank by 26.8% to $103M since the same quarter in the previous year.
Its net income has dropped by 200.3% to $-13M since the same quarter in the previous year.
Finally, its free cash flow grew by 449.0% to $27M since the same quarter in the previous year.
Based on the above factors, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd gets an overall score of 3/5.